Clinical Trials Browser

Phase EARLY_PHASE1 × Graft vs Host Disease × Rituximab × Clear all

NCT02484053 2018-07-11

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

Phase EARLY_PHASE1 Completed

Graft vs Host Disease, Hematologic Diseases, Lymphoma